Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07570251
Evaluation of Cognitive Education Activities in Breast Cancer Patients Receiving ChemotherapySaglik Bilimleri UniversitesiCompletedNot Applicable
NCT07570251Completed
Not Applicable
Evaluation of Cognitive Education Activities in Breast Cancer Patients Receiving...Saglik Bilimleri Universi...
NCT07570134
Simulation-Based Interprofessional Education for Operating Room TeamsYonsei UniversityNot Yet RecruitingNot Applicable
NCT07570134Not Yet Recruiting
Not Applicable
Simulation-Based Interprofessional Education for Operating Room TeamsYonsei University
NCT07569367
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia SpectrumBioSensicsNot Yet Recruiting
NCT07569367Not Yet Recruiting
—
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotem...BioSensics
NCT07569029
A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan AntibodiesDepartment of Health and Human Services (HHS)Not Yet RecruitingPhase 1
NCT07569029Not Yet Recruiting
Phase 1
A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA...Department of Health and...
NCT07569120
In Vivo Noradrenergic System and AgingHospices Civils de LyonNot Yet RecruitingNot Applicable
NCT07569120Not Yet Recruiting
Not Applicable
In Vivo Noradrenergic System and AgingHospices Civils de Lyon
NCT07569887
Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocognitive Disorders in Patients With Unruptured Arteriovenous Malformations Before and After Surgical TreatmentUniversity Hospital, MontpellierNot Yet RecruitingNot Applicable
NCT07569887Not Yet Recruiting
Not Applicable
Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocogni...University Hospital, Mont...
NCT07569861
Copeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of Polyuria-polydipsia SyndromeUniversity Hospital, Basel, SwitzerlandNot Yet RecruitingNot Applicable
NCT07569861Not Yet Recruiting
Not Applicable
Copeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of P...University Hospital, Base...
NCT07571057
Effects of an 8-week Jump Squat 15-m Swimming Start SwimmersFederal University of VicosaActive Not RecruitingNot Applicable
NCT07571057Active Not Recruiting
Not Applicable
Effects of an 8-week Jump Squat 15-m Swimming Start SwimmersFederal University of Vic...
NCT07571395
Median Nerve Electromyography to Monitor Intraoperative Neuromuscular FunctionPongrácz AdriennNot Yet Recruiting
NCT07571395Not Yet Recruiting
—
Median Nerve Electromyography to Monitor Intraoperative Neuromuscular FunctionPongrácz Adrienn
NCT07570004
THE EFFECT OF PREOPERATIVE ABDOMINAL MASSAGE ON THE POSTOPERATIVE CONSTIPATIONBurcu OzkanCompletedNot Applicable
NCT07570004Completed
Not Applicable
THE EFFECT OF PREOPERATIVE ABDOMINAL MASSAGE ON THE POSTOPERATIVE CONSTIPATIONBurcu Ozkan
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07570862
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus NephritisFate TherapeuticsNot Yet RecruitingPhase 2
NCT07570862Not Yet Recruiting
Phase 2
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Neph...Fate Therapeutics
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07570147
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Doses of ABBV-1451 Infusions and Injections in Healthy Adult ParticipantsAbbVieNot Yet RecruitingPhase 1
NCT07570147Not Yet Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Asc...AbbVie
NCT07570810
Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DMShanghai Jiao Tong University School of MedicineNot Yet RecruitingNot Applicable
NCT07570810Not Yet Recruiting
Not Applicable
Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD...Shanghai Jiao Tong Univer...
NCT07571330
Upper Punctal Plug Occlusion in Previous Lower Punctal Occlusion.Universidad Autonoma de Nuevo LeonRecruitingNot Applicable
NCT07571330Recruiting
Not Applicable
Upper Punctal Plug Occlusion in Previous Lower Punctal Occlusion.Universidad Autonoma de N...
NCT07570524
Predicting Response to Immunochemotherapy in Early Triple Negative Breast CancerCenter Eugene MarquisNot Yet Recruiting
NCT07570524Not Yet Recruiting
—
Predicting Response to Immunochemotherapy in Early Triple Negative Breast CancerCenter Eugene Marquis
NCT07569926
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical RecurrenceBlue Earth DiagnosticsNot Yet RecruitingPhase 4
NCT07569926Not Yet Recruiting
Phase 4
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Managemen...Blue Earth Diagnostics
NCT07568756
Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer EvaluationBlue Earth DiagnosticsNot Yet RecruitingPhase 2
NCT07568756Not Yet Recruiting
Phase 2
Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer Eval...Blue Earth Diagnostics
Result Breakdown
Not yet recruiting13 (65%)
Completed3 (15%)
Recruiting3 (15%)
Active, not recruiting1 (5%)
not_applicable11 (55%)
Not Specified3 (15%)
Phase 23 (15%)
Phase 12 (10%)
Phase 41 (5%)